凯姆菲罗尔通过Piezo1-介导的MAPK/NF-κB和Nrf2/HO-1信号通路调节巨细胞泡和动脉样硬化
Tianjiao Chu1, Yuman Wang2, Shihao Wang2
1Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Ji'nan 250355, PR China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, PR China.
Journal of advanced research
|November 19, 2024
概括
天然抗氧化剂凯姆菲罗尔通过抑制Piezo1通道和流量来预防动脉样硬化,从而减少泡细胞的形成. 这种机制涉及调节炎症因素,氧化应激和关键细胞通路.
科学领域:
- 心血管研究研究心血管研究
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉样硬化 (AS) 是一种复杂的疾病,其中像kaempferol这样的抗氧化剂显示出希望.
- 凯费醇发挥其抗动脉样硬化作用的精确机制,特别是在泡细胞形成中,仍然在很大程度上未被定义.
研究的目的:
- 阐明kaempferol对动脉样硬化的治疗作用背后的分子机制.
- 研究kaempferol在调节泡细胞积累和相关的炎症和氧化途径中的作用.
主要方法:
- 在暴露于ox-LDL的巨细胞中研究了kaempferol对炎症因素,CD36,线粒体潜力,ROS,MAPK/NF-κB,Nrf2/HO-1,Ca2+和Piezo1的影响.
- 使用Piezo1巨特异性淘汰小鼠 (Piezo1ΔLysM) 和ApoE-/-小鼠,包括Piezo1ΔLysM/ApoE-/-组合模型,以评估kaempferol在体内的疗效.
主要成果:
- 凯姆菲罗尔抑制了炎症,CD36表达,线粒体ROS,Ca2+流入和MAPK/NF-κB信号传递,同时增强了巨细胞中的Nrf2/HO-1.
- 宏细胞特定的Piezo1枯竭模仿了kaempferol的保护作用,减少了脂质积累和氧化应激.
- 在体内研究证实了kaempferol减少动脉样硬化斑块,在皮埃佐1贫乏小鼠中有效性降低.
结论:
- 凯姆菲罗尔抑制了Piezo1介导的Ca2+流入和随后的线粒体ROS产生,从而抑制了泡细胞的形成.
- 这种机制涉及调节CD36,NF-κB/MAPK和Nrf2/HO-1通路.
- 凯姆菲罗尔通过向Piezo1通道,代表了动脉样硬化的一种潜在的治疗剂.
相关概念视频
Inflammation
52.8K
Overview
52.8K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K


